257 related articles for article (PubMed ID: 21251016)
1. Immunological mechanisms of sublingual allergen-specific immunotherapy.
Novak N; Bieber T; Allam JP
Allergy; 2011 Jun; 66(6):733-9. PubMed ID: 21251016
[TBL] [Abstract][Full Text] [Related]
2. Local immunological mechanisms of sublingual immunotherapy.
Allam JP; Novak N
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):571-8. PubMed ID: 22001742
[TBL] [Abstract][Full Text] [Related]
3. Immune mechanisms of allergen-specific sublingual immunotherapy.
Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
[TBL] [Abstract][Full Text] [Related]
4. Immunological mechanisms of sublingual immunotherapy.
Allam JP; Novak N
Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):564-9. PubMed ID: 25233080
[TBL] [Abstract][Full Text] [Related]
5. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
Calderón MA; Simons FE; Malling HJ; Lockey RF; Moingeon P; Demoly P
Allergy; 2012 Mar; 67(3):302-11. PubMed ID: 22150126
[TBL] [Abstract][Full Text] [Related]
6. Immunological mechanisms of sublingual immunotherapy.
Akdis CA; Barlan IB; Bahceciler N; Akdis M
Allergy; 2006; 61 Suppl 81():11-4. PubMed ID: 16792600
[TBL] [Abstract][Full Text] [Related]
7. What do we need to learn to optimize the SLIT alternative?
Serra HM; Alignani DO; Passalacqua G; Canonica GW; Correa SG
Eur Ann Allergy Clin Immunol; 2006 May; 38(5):158-65. PubMed ID: 17058848
[TBL] [Abstract][Full Text] [Related]
8. Sublingual immunotherapy: from safety to mechanism of action.
Marcucci F; Sensi L; Allocca G; Chiarello F; Palleri P; Ugolini E; Di Rienzo A; Castellani S; Incorvaia C; Di Cara G; Puccinelli P; Frati F
Eur Ann Allergy Clin Immunol; 2007 Mar; 39(3):101-3. PubMed ID: 17465282
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells as potential targets for mucosal immunotherapy.
Allam JP; Bieber T; Novak N
Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):554-7. PubMed ID: 19745726
[TBL] [Abstract][Full Text] [Related]
10. Sublingual vaccines based on wild-type recombinant allergens.
Van Overtvelt L; Razafindratsita A; St-Lu N; Didierlaurent A; Batard T; Lombardi V; Martin E; Moingeon P
Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):247-9. PubMed ID: 17124785
[TBL] [Abstract][Full Text] [Related]
11. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy?
Allam JP; Stojanovski G; Friedrichs N; Peng W; Bieber T; Wenzel J; Novak N
Allergy; 2008 Jun; 63(6):720-7. PubMed ID: 18445186
[TBL] [Abstract][Full Text] [Related]
12. Repeated antigen painting and sublingual immunotherapy in mice convert sublingual dendritic cell subsets.
Zhang C; Ohno T; Kang S; Takai T; Azuma M
Vaccine; 2014 Sep; 32(43):5669-76. PubMed ID: 25168308
[TBL] [Abstract][Full Text] [Related]
13. [New administration routes for immunotherapy].
Martorell Aragonés A
Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
[TBL] [Abstract][Full Text] [Related]
14. The history of sublingual immunotherapy.
Pajno GB; Barberi S
Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):1-3. PubMed ID: 19944001
[TBL] [Abstract][Full Text] [Related]
15. Different immunotherapy applications--different mechanisms? SLIT versus SCIT--differences in the mode of action.
Allam JP; Bieber T; Novak N
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():237-40; discussion 240-5. PubMed ID: 20799467
[No Abstract] [Full Text] [Related]
16. Mucosal dendritic cells in allergy and immunotherapy.
Novak N; Allam JP
Allergy; 2011 Jul; 66 Suppl 95():22-4. PubMed ID: 21668846
[TBL] [Abstract][Full Text] [Related]
17. Mucosal immunity and sublingual immunotherapy in respiratory disorders.
Vitaliti G; Leonardi S; Miraglia Del Giudice M; Salpietro A; Artusio L; Caimmi D; Arrigo T; Salpietro C; Ciprandi G; La Rosa M
J Biol Regul Homeost Agents; 2012; 26(1 Suppl):S85-93. PubMed ID: 22691255
[TBL] [Abstract][Full Text] [Related]
18. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.
Bohle B; Kinaciyan T; Gerstmayr M; Radakovics A; Jahn-Schmid B; Ebner C
J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy with peptides.
Moldaver D; Larché M
Allergy; 2011 Jun; 66(6):784-91. PubMed ID: 21507007
[TBL] [Abstract][Full Text] [Related]
20. Update on immune mechanisms associated with sublingual immunotherapy: practical implications for the clinician.
Moingeon P
J Allergy Clin Immunol Pract; 2013; 1(3):228-41. PubMed ID: 24565479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]